S&P 500   5,033.14 (-0.36%)
DOW   37,799.34 (+0.00%)
QQQ   427.50 (-0.84%)
AAPL   168.72 (-0.39%)
MSFT   412.76 (-0.44%)
META   495.86 (-0.78%)
GOOGL   156.01 (+1.04%)
AMZN   181.69 (-0.89%)
TSLA   157.60 (+0.31%)
NVDA   852.62 (-2.46%)
AMD   156.35 (-4.35%)
NIO   3.95 (+3.67%)
BABA   69.21 (-0.57%)
T   16.14 (+0.31%)
F   12.12 (+0.25%)
MU   117.49 (-3.51%)
GE   155.44 (-0.84%)
CGC   6.67 (-0.45%)
DIS   113.52 (-0.32%)
AMC   2.95 (+8.46%)
PFE   25.46 (-0.90%)
PYPL   63.37 (-0.09%)
XOM   118.64 (-0.04%)
S&P 500   5,033.14 (-0.36%)
DOW   37,799.34 (+0.00%)
QQQ   427.50 (-0.84%)
AAPL   168.72 (-0.39%)
MSFT   412.76 (-0.44%)
META   495.86 (-0.78%)
GOOGL   156.01 (+1.04%)
AMZN   181.69 (-0.89%)
TSLA   157.60 (+0.31%)
NVDA   852.62 (-2.46%)
AMD   156.35 (-4.35%)
NIO   3.95 (+3.67%)
BABA   69.21 (-0.57%)
T   16.14 (+0.31%)
F   12.12 (+0.25%)
MU   117.49 (-3.51%)
GE   155.44 (-0.84%)
CGC   6.67 (-0.45%)
DIS   113.52 (-0.32%)
AMC   2.95 (+8.46%)
PFE   25.46 (-0.90%)
PYPL   63.37 (-0.09%)
XOM   118.64 (-0.04%)
S&P 500   5,033.14 (-0.36%)
DOW   37,799.34 (+0.00%)
QQQ   427.50 (-0.84%)
AAPL   168.72 (-0.39%)
MSFT   412.76 (-0.44%)
META   495.86 (-0.78%)
GOOGL   156.01 (+1.04%)
AMZN   181.69 (-0.89%)
TSLA   157.60 (+0.31%)
NVDA   852.62 (-2.46%)
AMD   156.35 (-4.35%)
NIO   3.95 (+3.67%)
BABA   69.21 (-0.57%)
T   16.14 (+0.31%)
F   12.12 (+0.25%)
MU   117.49 (-3.51%)
GE   155.44 (-0.84%)
CGC   6.67 (-0.45%)
DIS   113.52 (-0.32%)
AMC   2.95 (+8.46%)
PFE   25.46 (-0.90%)
PYPL   63.37 (-0.09%)
XOM   118.64 (-0.04%)
S&P 500   5,033.14 (-0.36%)
DOW   37,799.34 (+0.00%)
QQQ   427.50 (-0.84%)
AAPL   168.72 (-0.39%)
MSFT   412.76 (-0.44%)
META   495.86 (-0.78%)
GOOGL   156.01 (+1.04%)
AMZN   181.69 (-0.89%)
TSLA   157.60 (+0.31%)
NVDA   852.62 (-2.46%)
AMD   156.35 (-4.35%)
NIO   3.95 (+3.67%)
BABA   69.21 (-0.57%)
T   16.14 (+0.31%)
F   12.12 (+0.25%)
MU   117.49 (-3.51%)
GE   155.44 (-0.84%)
CGC   6.67 (-0.45%)
DIS   113.52 (-0.32%)
AMC   2.95 (+8.46%)
PFE   25.46 (-0.90%)
PYPL   63.37 (-0.09%)
XOM   118.64 (-0.04%)
OTCMKTS:ABMC

American Bio Medica (ABMC) Stock Price, News & Analysis

$0.0003
0.00 (0.00%)
(As of 04/16/2024 ET)
Today's Range
$0.0003
$0.0003
50-Day Range
N/A
52-Week Range
$0.0001
$0.0188
Volume
N/A
Average Volume
933 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ABMC stock logo

About American Bio Medica Stock (OTCMKTS:ABMC)

American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 16 drugs. The company also offers a test for the detection of respiratory syncytial virus; OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions of OralStat. In addition, the company distributes other products for the detection of substances of abuse, as well as products to detect certain infectious diseases. Further, it provides strip contract manufacturing, assembly, and packaging services to unaffiliated diagnostic companies. The company serves rehabilitation/drug treatment, pain management, other clinical, government, and employment/workplace markets. It operates in the United States, North America, Europe, the Asia Pacific, and South America. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992. American Bio Medica Corporation was incorporated in 1986 and is based in Kinderhook, New York.

ABMC Stock Price History

ABMC Stock News Headlines

American Bio Medica Corp.
American Bio Medica Corporation (ABMC)
IRS Loophole Gives Americans An Escape From Inflation
In the years immediately following 2008-09, as the economy stagnated, gold exploded in value. Today, Goldman Sachs is telling its clients that gold may reach $2,250 within the next few years. Don't miss your chance to diversify your savings.
ABMC American Bio Medica Corporation
IRS Loophole Gives Americans An Escape From Inflation
In the years immediately following 2008-09, as the economy stagnated, gold exploded in value. Today, Goldman Sachs is telling its clients that gold may reach $2,250 within the next few years. Don't miss your chance to diversify your savings.
8-K: AMERICAN BIO MEDICA CORP
American Bio Medica Corp (OTC: ABMC)
ABMC Reports Third Quarter 2021 Results
Medica Group PLC (MGPM)
ABMC Reports Second Quarter 2021 Results
See More Headlines
Receive ABMC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for American Bio Medica and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/14/2018
Today
4/17/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:ABMC
Employees
16
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$910,000.00
Book Value
($0.05) per share

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-0.65
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Ms. Jean Neff (Age 81)
    Corporate Secretary & Independent Director
    Comp: $3.75k
  • Mr. J. Duncan Urquhart (Age 70)
    Controller

ABMC Stock Analysis - Frequently Asked Questions

How have ABMC shares performed in 2024?

American Bio Medica's stock was trading at $0.0001 at the beginning of 2024. Since then, ABMC shares have increased by 200.0% and is now trading at $0.0003.
View the best growth stocks for 2024 here
.

How were American Bio Medica's earnings last quarter?

American Bio Medica Co. (OTCMKTS:ABMC) released its quarterly earnings data on Monday, May, 14th. The company reported ($0.01) EPS for the quarter. The business earned $1.04 million during the quarter.

What other stocks do shareholders of American Bio Medica own?

Based on aggregate information from My MarketBeat watchlists, some companies that other American Bio Medica investors own include OPKO Health (OPK), Canadian Western Bank (CWB), RespireRx Pharmaceuticals (RSPI), Workhorse Group (WKHS), Bank of Nova Scotia (BNS), (DFT) (DFT), Gilead Sciences (GILD), ServiceNow (NOW) and Block (SQ).

How do I buy shares of American Bio Medica?

Shares of ABMC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ABMC) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners